Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Morningside Group
AddedMar 19, 2024
UpdatedJun 28, 2026
Morningside Group

Morningside Group

Operating

Global financial services firm in Newton Center, MA. Morningside Venture Investments: industry investments with social responsibility, founded in 1986, Shanghai.

Location
Newton Centre, MA, US
Founded
1986
Firm
Compare
Portfolio
Employees
Website

Investments

Jitjatjo
Jitjatjo

Total Raised

$47.9M

Rounds

4

Series B$30MDecember 2023
Resilience Lab
Resilience Lab

Total Raised

$15M

Rounds

2

Series A$15MNovember 2022
Valitor
Valitor
Series B

Total Raised

$39M

Rounds

4

Series B$28MOctober 2022
Airspace Link
Airspace Link
Series B

Total Raised

$38M

Rounds

4

Series B$23MJune 2022
Eko Health
Eko Health

Total Raised

$128.2M

Rounds

10

Series C$30MMarch 2022
Casana
Casana

Total Raised

$56.3M

Rounds

6

Series B$40MJanuary 2022
Big Health
Big Health

Total Raised

$129.3M

Rounds

4

Series C$75MJanuary 2022
Almond FinTech
Almond FinTech

Total Raised

$9M

Rounds

2

Seed$2MDecember 2021
Generate Biomedicines
Generate Biomedicines

Total Raised

$693M

Rounds

3

Series B$370MNovember 2021
Geneoscopy
Geneoscopy

Total Raised

$112.9M

Rounds

4

Series B$105MNovember 2021
CloudMosa
CloudMosa

Total Raised

$51.6M

Rounds

2

Series B$30MNovember 2021
Easy Expunctions
Easy Expunctions

Total Raised

$11.4M

Rounds

5

Series A$6.3MNovember 2021
Block Renovation
Block Renovation

Total Raised

$104M

Rounds

4

Series C$50MNovember 2021
Series B$39.5MJuly 2021
DeepCure
DeepCure

Total Raised

$40M

Rounds

3

Series A$40MNovember 2021
Robigo
Robigo

Total Raised

$8M

Rounds

3

Pre-Seed$1.1MNovember 2021
Huckleberry Labs
Huckleberry Labs

Total Raised

$16.1M

Rounds

3

Series A$12.5MNovember 2021
Kappa Pay
Kappa Pay

Total Raised

$3.6M

Rounds

2

Pre-Seed$2.1MOctober 2021
BetterUp
BetterUp

Total Raised

$569.8M

Rounds

7

Series E$300MOctober 2021
Exo Therapeutics
Exo Therapeutics

Total Raised

$103M

Rounds

2

Series B$78MOctober 2021
Homee
Homee

Total Raised

$50.3M

Rounds

5

Series B$17MSeptember 2021
Alamar Biosciences
Alamar Biosciences
Series C

Total Raised

$222M

Rounds

3

Series B$80MSeptember 2021
MedRhythms
MedRhythms

Total Raised

$54M

Rounds

13

Series B$25MJuly 2021
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals
Public

Total Raised

$448.5M

Rounds

9

Series C$135MJuly 2021
Fount Bio
Fount Bio

Total Raised

$8.2M

Rounds

1

Series A$8.2MJuly 2021